RECRUITING

Stress and Congestive Heart Failure

Talk to us

Conditions

Congestive Heart Failure

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to investigate whether acute stress can precipitate congestive heart failure (CHF) exacerbation in patients with CHF.

Official Title

Stress and Congestive Heart Failure

Quick Facts

Study Start:2020-12-02
Study Completion:2026-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04551560

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Patients who are unable to perform EMA or laboratory assessments due to cognitive, visual, language, or other disabilities will be excluded.
  2. * Patients with Class IV heart failure will also be excluded, as they are already maximally decompensated, and a ceiling/floor effect would preclude effects of stress.
  3. * Patients with conditions other than heart failure that affect PA pressures (e.g. dialysis).
  4. * Patients with physical conditions that interfere with study participation.
  5. * Patients non-compliant with their PAP monitoring.
  6. * Patients with chronic opioid use will be excluded.

Contacts and Locations

Study Contact

Rachel Lampert, MD
CONTACT
(203) 737-4068
rachel.lampert@yale.edu
Matthew Burg
CONTACT
203-932-5711
matthew.burg@yale.edu

Principal Investigator

Rachel Lampert, MD
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

St. Francis Hospital
Hartford, Connecticut, 06105
United States
Hartford HealthCare
Hartford, Connecticut, 06106
United States
Yale University
New Haven, Connecticut, 06511
United States

Collaborators and Investigators

Sponsor: Yale University

  • Rachel Lampert, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-02
Study Completion Date2026-01-01

Study Record Updates

Study Start Date2020-12-02
Study Completion Date2026-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Congestive Heart Failure